Effects of Internet Support for Cancer Patients

Not Applicable

Completed

• Conditions: Breast Cancer
• Interventions: Behavioral: WebChoice IHCA; Behavioral: OPPC service

• Registration Number: NCT00971009
• Lead Sponsor: Oslo University Hospital

Brief Summary

Being diagnosed and treated for cancer is usually associated with severe physical symptoms, impaired functional status, complex emotional, psychosocial and existential issues and substantial worries. Failure to help patients with their problems and worries can unnecessarily delay patients' recovery and rehabilitation, lead to chronic functional impairments, anxiety and depression and prolong patients' needs for health care and social services. The objectives of this interdisciplinary, international research project that includes collaboration with HELFO (The Norwegian Health Economy Administration), are to test and compare, in a randomized, controlled trial (RCT), the effects of (1) a practice-integrated online patient-provider communication (OPPC) service including access to asking questions to HELFO, (2) a multi-component Interactive Health Communication Application (IHCA) called WebChoice, and (3) usual care on: patient outcomes, health care and social services use and costs. Breast cancer patients undergoing treatment at three different hospitals in Norway will be randomized into two experimental and one control groups and will be followed with 5 repeated measures over one year. The proposed study will contribute to innovative methods and technologies that can radically improve patient-provider communication, care quality, and continuity of care. The two interventions tested in this study, the OPPC service with and without additional features of WebChoice, represent new forms of interactions and information sharing between patients and clinicians where patients can get seamless access to communication and information services from where and whenever they need it. This could significantly contribute to reducing unnecessary suffering, less fragmented health care, better efficiency, patient safety, patient satisfaction and have an impact on patients' health services utilization. The investigators' work addresses, therefore, important health policy goals with the potential for considerable societal gains.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-09-01
• Study First Submitted QC: 2009-09-02
• Study First Posted: 2009-09-03
• Study Start: 2010-03
• Primary Completion: 2014-03
• Study Completion: 2015-07
• Status Verified: 2015-10
• Last Update Submitted: 2015-10-19
• Last Update Posted: 2015-10-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

• Patients recently diagnosed with breast cancer and under treatment (radiation, chemotherapy, hormone, or combinations of those)
• Patients are > 18 years of age, able to write / read / speak Norwegian and have Internet with secure access (BankID) at home

Exclusion Criteria

• Excluded are patients who had received radiation on the brain as this may affect their abilities to reliably report their symptoms

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
WebChoice IHCA	WebChoice IHCA	WebChoice is an interactive health communications application (IHCA) that in addition to offer a practice-integrated nurse administered online patient-provider communication (OPPC) service, allows patients to monitor their symptoms and health problems from home; provides them with individually tailored, just-in-time information and support to manage their symptoms and illness-related problems between treatments and during rehabilitation; and a forum, or e-group community, for group discussion with other cancer patients.
OPPC service	OPPC service	A practice-integrated nurse administered online patient-provider communication (OPPC) service including access to asking questions to social counselors

Primary Outcome Measures

Name	Time	Method
Anxiety and depression	At baseline an at 2, 4, 6, 8 and 12 months
Severity and duration of symptom distress	At baseline and at 2, 4, 6, 8 and 12 months

Secondary Outcome Measures

Name	Time	Method
Self-efficacy	At baseline and at 2, 4, 6, 8 and 12 months
Uncertainty in illness	At baseline and at 2, 4, 6, 8 and 12 months
Quality of life	At baseline and at 4, 8 and 12 months
Health care costs	Post intervention, at 12 and 18 months

Trial Locations

Locations (1)

Oslo University Hospital - Rikshospitalet; 🇳🇴 Oslo, Norway